Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
FDA established a PDUFA action date for ATI-1501 of September 23, 2023
Government funding committed to enable Appili to advance its biodefense vaccine candidate ATI-1701 towards an IND
.